These consistent expression patterns suggest that UCP2 may function as an oncogene in diverse cancer contexts, while UCP1, UCP3, SLC25A27, and SLC25A14 are potentially involved in tumor-suppressive mechanisms. This evidence concerns the gene UCP1 and neoplasm.